NCT04660773 is a Phase 2 clinical trial of NB UVB phototherapy in Refractory Uremic Pruritis, sponsored by Alexandria University.

Who is sponsoring NCT04660773?

NCT04660773 is sponsored by Alexandria University.

What drugs are being tested in NCT04660773?

Interventions in NCT04660773: NB UVB phototherapy, Pregabalin.

What condition does NCT04660773 study?

NCT04660773 studies Refractory Uremic Pruritis.

Is NCT04660773 still recruiting?

NCT04660773 is currently status unknown. Last updated 26 July 2021.

Last reviewed 2021-07-26 · How we verify

NCT04660773

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PHOTOTHERAPY VERSUS PREGABALIN IN TREATMENT OF REFRACTORY UREAMIC PRURITIS

Status unknown Phase 2 Last updated 26 July 2021

What this trial tests

Phase 2 trial testing NB UVB phototherapy in Refractory Uremic Pruritis in 40 participants. Status unknown.

Timeline

1 August 2021

Primary endpoint
1 March 2022

1 March 2022

Quick facts

Lead sponsor	Alexandria University
Phase	Phase 2
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	1 August 2021
Primary completion	1 March 2022
Estimated completion	1 March 2022
Sites	1 location across Egypt

Drugs / interventions tested

NB UVB phototherapy
Pregabalin (Pregabalin) — full drug profile →

Conditions studied

Refractory Uremic Pruritis — all drugs for Refractory Uremic Pruritis →

Sponsor

Alexandria University

Who can join

Adults 20 to 60, any sex, with Refractory Uremic Pruritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients will be randomly assigned into 2 groups: 1. Group A: (20 patients) will receive NB UVB phototherapy 3 sessions per week for 2 months. 2. Group B: (20 patients) will receive pregabalin oral therapy (50mg after each dialysis session) for 2 months.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Pharmacological interventions for pruritus in adult palliative care patients.
Boehlke C, Joos L, Coune B, Becker C, et al · · 2023 · cited 10× · PMID 37314034 · DOI 10.1002/14651858.cd008320.pub4

Verify or expand the search:

Other Alexandria University trials

Trials by the same sponsor.

NCT07517861 — Integrated Mental Health Nursing Program: Effects on Stigma, Cognitive Flexibility, and Clinical Readiness · NA · recruiting
NCT07476482 — The Impact of a Shared Decision-Making Intervention on Intraoperative Patient Experience During Elective Cesarean Delive · NA · enrolling by invitation
NCT07476209 — Sialendoscopy Versus Photobiomodulation in Prevention of Radiation Induced Xerostomia · NA · recruiting
NCT07503626 — Optimization of Orthodontic Bracket Placement by Using Two Different Protocols of Digitally Aided Bonding · NA · recruiting
NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04660773 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alexandria University
Last refreshed: 26 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04660773.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing